Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophilic leukaemia.

Sarah Fletcher1, Barbara Bain

  • 1Department of Haematology, St Mary's Hospital, Campus of Imperial College, London, UK.

British Medical Bulletin
|April 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Molecular therapy. Advances·2026
Same author

The Learning Cycle method: an approach to rapidly bring evidence to the point of decision-making for health system planning.

Health research policy and systems·2026
Same author

Human factors in digital manufacturing technology adoption: a workforce perspective.

The International journal, advanced manufacturing technology·2025
Same author

Feline infectious peritonitis epizootic caused by a recombinant coronavirus.

Nature·2025
Same author

Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease.

Nature communications·2025
Same author

Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.

Antiviral research·2024

Recent advancements have improved the diagnosis and treatment of eosinophilic leukaemia. Molecular genetic classification aids in prognostication and personalized therapy, with tyrosine kinase inhibitors revolutionizing patient outcomes.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Eosinophilic leukaemia diagnosis and treatment have seen significant advancements.
  • Understanding clonal eosinophilias is crucial for effective management.

Purpose of the Study:

  • To review the differential diagnosis and sub-classification of eosinophilic leukaemia.
  • To discuss clinical features, investigation, and treatment strategies.
  • To highlight recent therapeutic breakthroughs and future directions.

Main Methods:

  • Literature search of PubMed and major Haematology journals.
  • Focus on research and reviews published in the last 5-10 years.
  • Synthesis of information on classification, clinical aspects, and treatment.

Main Results:

Related Experiment Videos

  • Eosinophilic leukaemia can be classified based on molecular genetic abnormalities.
  • Imatinib treatment has shown revolutionary success in certain patients.
  • New tyrosine kinase inhibitors and therapies are emerging.

Conclusions:

  • Molecular classification improves prognostication and treatment personalization.
  • Targeted therapies, like imatinib, have transformed outcomes.
  • Ongoing research promises further therapeutic advancements for eosinophilic leukaemia.